Table 4.
Males | Females | Total | |||
---|---|---|---|---|---|
N (%)f | N (%)f | N (%)f | |||
Population-based case familiesa | Probands | Baseline questionnaire | 4321 (22.5) | 4419 (18.9) | 8740 (20.6) |
Food frequency questionnaire | 2096 (22.7) | 2409 (20.5) | 4505 (21.5) | ||
Blood/buccal samples | 3759 (27.3) | 3886 (22.8) | 7645 (24.8) | ||
Polyp material | 14 (7.9) | 8 (4.0) | 22 (5.8) | ||
Cancer material | 3561 (73.6) | 3447 (70.2) | 7008 (71.9) | ||
Diagnosis and treatment | 1563 (84.2) | 1526 (85.7) | 3089 (85.0) | ||
Relativesb | Baseline questionnaire | 7740 (40.4) | 10328 (44.3) | 18068 (42.5) | |
Food frequency questionnaire | 3323 (36.0) | 4700 (40.0) | 8023 (38.3) | ||
Blood/buccal samples | 4751 (34.4) | 6731 (39.5) | 11482 (37.2) | ||
Polyp material | 7 (3.9) | 8 (4.0) | 15 (3.9) | ||
Cancer material | 265 (5.5) | 325 (6.6) | 590 (6.1) | ||
Diagnosis and treatment | 40 (2.2) | 44 (2.5) | 84 (2.3) | ||
Spouse controlsc | Baseline questionnaire | 361 (1.9) | 560 (2.4) | 921 (2.2) | |
Food frequency questionnaire | 135 (1.5) | 197 (1.7) | 332 (1.6) | ||
Blood/buccal samples | 149 (1.1) | 225 (1.3) | 374 (1.2) | ||
Population-based control familiesd | Probands | Baseline questionnaire | 2071 (10.8) | 2205 (9.5) | 4276 (10.1) |
Food frequency questionnaire | 1142 (12.4) | 1023 (8.7) | 2165 (10.3) | ||
Blood/buccal samples | 1399 (10.1) | 1497 (8.8) | 2896 (9.4) | ||
Relativesb | Baseline epi data | 310 (1.6) | 467 (2.0) | 777 (1.8) | |
Food frequency questionnaire | 260 (2.8) | 383 (3.3) | 643 (3.1) | ||
Blood/buccal samples | 6 (0.0) | 5 (0.0) | 11 (0.0) | ||
Clinic-based Colon Cancer familiese | Probands with CRCa | Baseline questionnaire | 699 (3.6) | 644 (2.8) | 1343 (3.2) |
Food frequency questionnaire | 247 (2.7) | 270 (2.3) | 517 (2.5) | ||
Blood/buccal samples | 645 (4.7) | 625 (3.7) | 1270 (4.1) | ||
Polyp material | 24 (13.5) | 29 (14.4) | 53 (13.9) | ||
Cancer material | 561 (11.6) | 526 (10.7) | 1087 (11.2) | ||
Diagnosis and treatment | 239 (12.9) | 204 (11.5) | 443 (12.2) | ||
Probands no CRCc | Baseline questionnaire | 137 (0.7) | 304 (1.3) | 441 (1.0) | |
Food frequency questionnaire | 62 (0.7) | 164 (1.4) | 226 (1.1) | ||
Blood/buccal samples | 101 (0.7) | 250 (1.5) | 351 (1.1) | ||
Polyp material | 13 (7.3) | 27 (13.4) | 40 (10.5) | ||
Cancer material | 20 (0.4) | 67 (1.4) | 87 (0.9) | ||
Diagnosis and treatment | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Relativesb | Baseline questionnaire | 3524 (18.4) | 4399 (18.9) | 7923 (18.6) | |
Food frequency questionnaire | 1953 (21.2) | 2596 (22.1) | 4549 (21.7) | ||
Blood/buccal samples | 2983 (21.6) | 3814 (22.4) | 6797 (22.0) | ||
Polyp material | 120 (67.4) | 130 (64.4) | 250 (65.8) | ||
Cancer material | 429 (8.9) | 542 (11.0) | 971 (10.0) | ||
Diagnosis and treatment | 14 (0.8) | 6 (0.3) | 20 (0.6) | ||
Total | All population- and clinic-based probands and relatives | Baseline questionnaire | 19163 | 23326 | 42489 |
Food frequency questionnaire | 9218 | 11742 | 20960 | ||
Blood/buccal samples | 13793 | 17033 | 30826 | ||
Polyp material | 178 | 202 | 380 | ||
Cancer material | 4836 | 4907 | 9743 | ||
Diagnosis and treatment | 1856 | 1780 | 3636 |
Proband had a history of colorectal cancer (CRC) at baseline interview.
Affected or unaffected with colorectal cancer at baseline interview.
Spouse of proband, had no history of colorectal cancer at baseline interview.
Proband had no history of colorectal cancer at baseline interview.
Proband was recruited from a family cancer clinic.
% of total items obtained. For example 20.6% of all baseline questionnaires completed by probands of population-based case families.